“BriaCell Kicks Off Breakthrough Phase 3 Study for Late-Stage Breast Cancer Treatment
Briacell, an immuno-oncology company focused on developing therapeutics to target tumor-specific antigen generation and T-cell response, has successfully initiated a...
